ENDOLOGIX INC's ticker is and the CUSIP is 29266SAB2. A total of 10 filers reported holding ENDOLOGIX INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 3,500,000 | $3,793,000 | 5.91% |
| FNY Managed Accounts LLC | 500,000 | $542,190,000 | 2.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 30,000,000 | $32,548,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 13,906,000 | $15,123,000 | 0.71% |
| DAFNA Capital Management LLC | 500,000 | $545,000 | 0.49% |
| SSI INVESTMENT MANAGEMENT LLC | 4,000,000 | $4,308,000 | 0.44% |
| CAMDEN ASSET MANAGEMENT L P /CA | 9,100,000 | $9,868,000 | 0.31% |
| LINDEN ADVISORS LP | 4,500,000 | $4,896,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,000,000 | $11,949,000 | 0.26% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 300,000 | $327,000 | 0.05% |